{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:11:04Z","timestamp":1790428264619,"version":"4.1.0"},"reference-count":233,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602257"],"award-info":[{"award-number":["81602257"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013061","name":"Jilin Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["20190101010JH"],"award-info":[{"award-number":["20190101010JH"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.01510","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T12:46:29Z","timestamp":1598013989000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":163,"title":["Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy"],"prefix":"10.3389","volume":"10","author":[{"given":"Linyuan","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang Jason","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11603","DOI":"10.1073\/pnas.90.24.11603","article-title":"SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element","volume":"90","author":"Hua","year":"1993","journal-title":"Proc Natl Acad Sci USA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0092-8674(05)80095-9","article-title":"SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene","volume":"75","author":"Yokoyama","year":"1993","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2005.12.022","article-title":"Protein sensors for membrane sterols","volume":"124","author":"Goldstein","year":"2006","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1172\/JCI2961","article-title":"Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2","volume":"101","author":"Horton","year":"1998","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"35832","DOI":"10.1074\/jbc.274.50.35832","article-title":"Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes","volume":"274","author":"Shimano","year":"1999","journal-title":"J Biol Chem"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1194\/jlr.M100417-JLR200","article-title":"Transcriptional activities of nuclear SREBP-1a,\u22121c, and\u22122 to different target promoters of lipogenic and cholesterogenic genes","volume":"43","author":"Amemiya-Kudo","year":"2002","journal-title":"J Lipid Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1101\/gad.1854309","article-title":"Evolutionary conservation and adaptation in the mechanism that regulates SREBP action: what a long, strange tRIP it's been","volume":"23","author":"Osborne","year":"2009","journal-title":"Genes Dev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tem.2011.10.004","article-title":"SREBPs: metabolic integrators in physiology and metabolism","volume":"23","author":"Jeon","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cmet.2012.09.002","article-title":"Expanding roles for SREBP in metabolism","volume":"16","author":"Shao","year":"2012","journal-title":"Cell Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.cmet.2011.12.017","article-title":"The Scap\/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals","volume":"15","author":"Moon","year":"2012","journal-title":"Cell Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2049-3002-1-3","article-title":"Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth","volume":"1","author":"Griffiths","year":"2013","journal-title":"Cancer Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"12869","DOI":"10.18632\/oncotarget.7331","article-title":"SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"B15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bbadis.2018.10.026","article-title":"SREBP-2 aggravates breast cancer associated osteolysis by promoting osteoclastogenesis and breast cancer metastasis","volume":"1865","author":"Jie","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.3892\/mmr.2019.10577","article-title":"SREBP2 is upregulated in esophageal squamous cell carcinoma and cooperates with cMyc to regulate HMGCR expression","volume":"20","author":"Zhong","year":"2019","journal-title":"Mol Med Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.canlet.2014.01.013","article-title":"Mevalonate metabolism in cancer","volume":"356","author":"Gruenbacher","year":"2015","journal-title":"Cancer Lett."},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/1874467209666160112123205","article-title":"Mevalonate pathway and human cancers","volume":"10","author":"Bathaie","year":"2017","journal-title":"Curr Mol Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1158\/0008-5472.CAN-10-4108","article-title":"Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigen","volume":"71","author":"Yamauchi","year":"2011","journal-title":"Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.cell.2011.12.017","article-title":"Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway","volume":"148","author":"Freed-Pastor","year":"2012","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2018.11.011","article-title":"p53 represses the mevalonate pathway to mediate tumor suppression","volume":"176","author":"Moon","year":"2019","journal-title":"Cell."},{"key":"B22","doi-asserted-by":"crossref","first-page":"17267","DOI":"10.1016\/S0021-9258(17)32550-4","article-title":"Assignment of the membrane attachment, DNA binding, and transcriptional activation domains of sterol regulatory element-binding protein-1 (SREBP-1)","volume":"269","author":"Sato","year":"1994","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1172\/JCI119248","article-title":"Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells","volume":"99","author":"Shimano","year":"1997","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.3748\/wjg.v10.i21.3081","article-title":"Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins","volume":"10","author":"Weber","year":"2004","journal-title":"World J Gastroenterol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"12753","DOI":"10.1073\/pnas.162488899","article-title":"Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins","volume":"99","author":"Yabe","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0092-8674(02)00872-3","article-title":"Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER","volume":"110","author":"Yang","year":"2002","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"26483","DOI":"10.1074\/jbc.M504041200","article-title":"Insig required for sterol-mediated inhibition of Scap\/SREBP binding to COPII proteins in vitro","volume":"280","author":"Sun","year":"2005","journal-title":"J Biol Chem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1146\/annurev-biochem-062917-011852","article-title":"Retrospective on cholesterol homeostasis: the central role of scap","volume":"87","author":"Brown","year":"2018","journal-title":"Annu Rev Biochem"},{"key":"B29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S1097-2765(00)80150-1","article-title":"Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells","volume":"2","author":"Sakai","year":"1998","journal-title":"Mol Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S1097-2765(00)80006-4","article-title":"Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs","volume":"1","author":"Rawson","year":"1997","journal-title":"Mol Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.cmet.2008.10.008","article-title":"Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance","volume":"8","author":"Radhakrishnan","year":"2008","journal-title":"Cell Metab"},{"key":"B32","doi-asserted-by":"publisher","first-page":"16672","DOI":"10.1073\/pnas.262669399","article-title":"Three mutations in sterol-sensing domain of SCAP block interaction with insig and render SREBP cleavage insensitive to sterols","volume":"99","author":"Yabe","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1074\/jbc.M116.767277","article-title":"Heat shock protein 90 modulates lipid homeostasis by regulating the stability and function of Sterol Regulatory Element-binding Protein (SREBP) and SREBP cleavage-activating protein","volume":"292","author":"Kuan","year":"2017","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","first-page":"28995","DOI":"10.1074\/jbc.M109.041376","article-title":"The sterol-sensing endoplasmic reticulum (ER) membrane protein TRC8 hampers ER to Golgi transport of sterol regulatory element-binding protein-2. (SREBP-2)\/SREBP cleavage-activated protein and reduces SREBP-2 cleavage","volume":"284","author":"Irisawa","year":"2009","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2005.11.014","article-title":"Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake","volume":"3","author":"Gong","year":"2006","journal-title":"Cell Metab"},{"key":"B36","doi-asserted-by":"publisher","first-page":"39308","DOI":"10.1074\/jbc.M608999200","article-title":"Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78","volume":"281","author":"Lee","year":"2006","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.1073\/pnas.0700899104","article-title":"Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig","volume":"104","author":"Radhakrishnan","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1073\/pnas.0500206102","article-title":"Intramembrane aspartic acid in SCAP protein governs cholesterol-induced conformational change","volume":"102","author":"Feramisco","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/19768354.2017.1336483","article-title":"Regulation of INSIG2 by microRNA-96","volume":"21","author":"Jo","year":"2017","journal-title":"Anim Cells Syst"},{"key":"B40","doi-asserted-by":"publisher","first-page":"8100","DOI":"10.1038\/ncomms9100","article-title":"PAQR3 modulates cholesterol homeostasis by anchoring Scap\/SREBP complex to the Golgi apparatus","volume":"6","author":"Xu","year":"2015","journal-title":"Nat Commun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e28766","DOI":"10.7554\/eLife.28766","article-title":"Inhibition of cholesterol biosynthesis through RNF145-dependent ubiquitination of SCAP","volume":"6","author":"Zhang","year":"2017","journal-title":"Elife"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1091\/mbc.e05-11-1094","article-title":"Involvement of Akt in ER-to-Golgi transport of SCAP\/SREBP: a link between a key cell proliferative pathway and membrane synthesis","volume":"17","author":"Du","year":"2006","journal-title":"Mol Biol Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.bbamcr.2011.09.017","article-title":"Akt acutely activates the cholesterogenic transcription factor SREBP-2","volume":"1823","author":"Luu","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B44","doi-asserted-by":"publisher","first-page":"ra111","DOI":"10.1126\/scisignal.aac5124","article-title":"Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake","volume":"8","author":"Haskins","year":"2015","journal-title":"Sci Signal"},{"key":"B45","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1042\/BST0390495","article-title":"Regulation of the SREBP transcription factors by mTORC1","volume":"39","author":"Lewis","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"B46","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","article-title":"mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway","volume":"146","author":"Peterson","year":"2011","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1073\/pnas.1705304114","article-title":"mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells","volume":"114","author":"Eid","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B48","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.bcp.2006.10.027","article-title":"Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2","volume":"73","author":"Konig","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cmet.2005.04.010","article-title":"Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7)","volume":"1","author":"Sundqvist","year":"2005","journal-title":"Cell Metab"},{"key":"B50","doi-asserted-by":"publisher","first-page":"22404","DOI":"10.1074\/jbc.M401198200","article-title":"Insulin-activated Erk-mitogen-activated protein kinases phosphorylate sterol regulatory element-binding Protein-2 at serine residues 432 and 455 in vivo","volume":"279","author":"Kotzka","year":"2004","journal-title":"J Biol Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice","volume":"13","author":"Li","year":"2011","journal-title":"Cell Metab"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1128\/MCB.23.7.2587-2599.2003","article-title":"Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors","volume":"23","author":"Giandomenico","year":"2003","journal-title":"Mol Cell Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1101\/gad.1901210","article-title":"Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid\/cholesterol regulator SREBP","volume":"24","author":"Walker","year":"2010","journal-title":"Genes Dev"},{"key":"B54","doi-asserted-by":"publisher","first-page":"16809","DOI":"10.1074\/jbc.M212448200","article-title":"Sterol regulatory element-binding proteins are negatively regulated through SUMO-1 modification independent of the ubiquitin\/26 S proteasome pathway","volume":"278","author":"Hirano","year":"2003","journal-title":"J Biol Chem"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/oxfordjournals.jbchem.a022060","article-title":"Multiple DNA elements for sterol regulatory element-binding protein and NF-Y are responsible for sterol-regulated transcription of the genes for human 3-hydroxy-3-methylglutaryl coenzyme A synthase and squalene synthase","volume":"123","author":"Inoue","year":"1998","journal-title":"J Biochem"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.bbalip.2012.07.006","article-title":"Sterols regulate 3beta-hydroxysterol Delta24-reductase (DHCR24) via dual sterol regulatory elements: cooperative induction of key enzymes in lipid synthesis by Sterol Regulatory Element Binding Proteins","volume":"1821","author":"Zerenturk","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B57","doi-asserted-by":"publisher","first-page":"12027","DOI":"10.1073\/pnas.1534923100","article-title":"Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes","volume":"100","author":"Horton","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B58","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.abb.2010.09.028","article-title":"Enzymes of the mevalonate pathway of isoprenoid biosynthesis","volume":"505","author":"Miziorko","year":"2011","journal-title":"Arch Biochem Biophys"},{"key":"B59","doi-asserted-by":"publisher","first-page":"188351","DOI":"10.1016\/j.bbcan.2020.188351","article-title":"Cholesterol and beyond - the role of the mevalonate pathway in cancer biology","volume":"1873","author":"Gobel","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1399-0004.2008.01099.x","article-title":"Squalene synthase: a critical enzyme in the cholesterol biosynthesis pathway","volume":"75","author":"Do","year":"2009","journal-title":"Clin Genet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.steroids.2018.12.003","article-title":"Cholesterol biosensors: a review","volume":"143","author":"Narwal","year":"2019","journal-title":"Steroids"},{"key":"B63","doi-asserted-by":"publisher","first-page":"21090","DOI":"10.1074\/jbc.M701228200","article-title":"Sterol regulatory element-binding protein-2- and liver X receptor-driven dual promoter regulation of hepatic ABC transporter A1 gene expression: mechanism underlying the unique response to cellular cholesterol status","volume":"282","author":"Tamehiro","year":"2007","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1042\/BJ20060914","article-title":"SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR","volume":"400","author":"Wong","year":"2006","journal-title":"Biochem J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.cca.2009.12.027","article-title":"Regulation of cholesterol homeostasis by liver X receptors","volume":"411","author":"Hu","year":"2010","journal-title":"Clin Chim Acta"},{"key":"B66","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41556-017-0009-8","article-title":"Mechanical cues control mutant p53 stability through a mevalonate-RhoA axis","volume":"20","author":"Ingallina","year":"2018","journal-title":"Nat Cell Biol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ncb2936","article-title":"Metabolic control of YAP and TAZ by the mevalonate pathway","volume":"16","author":"Sorrentino","year":"2014","journal-title":"Nat Cell Biol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41418-017-0026-y","article-title":"The interplay between mutant p53 and the mevalonate pathway","volume":"25","author":"Parrales","year":"2018","journal-title":"Cell Death Differ"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","article-title":"Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma","volume":"140","author":"Calvisi","year":"2011","journal-title":"Gastroenterology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/jcb.21757","article-title":"Regulation of HMG-CoA reductase expression by hypoxia","volume":"104","author":"Pallottini","year":"2008","journal-title":"J Cell Biochem"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.celrep.2017.02.006","article-title":"Extracellular acidic pH activates the sterol regulatory element-binding protein 2 to promote tumor progression","volume":"18","author":"Kondo","year":"2017","journal-title":"Cell Rep"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e1132120","DOI":"10.1080\/23723556.2015.1132120","article-title":"SCAP links glucose to lipid metabolism in cancer cells","volume":"3","author":"Guo","year":"2016","journal-title":"Mol Cell Oncol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1210\/mend.15.10.0703","article-title":"Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein\/sterol regulatory element-binding protein pathway","volume":"15","author":"Heemers","year":"2001","journal-title":"Mol Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/pros.20325","article-title":"Androgen regulation of prostasin gene expression is mediated by sterol-regulatory element-binding proteins and SLUG","volume":"66","author":"Chen","year":"2006","journal-title":"Prostate"},{"key":"B75","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/j.1432-1033.1996.0800p.x","article-title":"Analysis of the specificity of the AMP-activated protein kinase by site-directed mutagenesis of bacterially expressed 3-hydroxy 3-methylglutaryl-CoA reductase, using a single primer variant of the unique-site-elimination method","volume":"237","author":"Ching","year":"1996","journal-title":"Eur J Biochem"},{"key":"B76","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0014-5793(97)00890-9","article-title":"Distinct type-2A protein phosphatases activate HMGCoA reductase and acetyl-CoA carboxylase in liver","volume":"413","author":"Gaussin","year":"1997","journal-title":"FEBS Lett"},{"key":"B77","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1097-2765(02)00822-5","article-title":"Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain","volume":"11","author":"Sever","year":"2003","journal-title":"Mol Cell"},{"key":"B78","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.1091\/mbc.e12-08-0631","article-title":"Differential regulation of HMG-CoA reductase and Insig-1 by enzymes of the ubiquitin-proteasome system","volume":"23","author":"Tsai","year":"2012","journal-title":"Mol Biol Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jphs.2018.09.013","article-title":"PPARgamma overexpression regulates cholesterol metabolism in human L02 hepatocytes","volume":"139","author":"Han","year":"2019","journal-title":"J Pharmacol Sci"},{"key":"B80","doi-asserted-by":"publisher","first-page":"26332","DOI":"10.1074\/jbc.M804808200","article-title":"Regulation of cholesterologenesis by the oxysterol receptor, LXRalpha","volume":"283","author":"Wang","year":"2008","journal-title":"J Biol Chem"},{"key":"B81","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000362363","article-title":"Desmosterol in brain is elevated because DHCR24 needs REST for Robust Expression but REST is poorly expressed","volume":"36","author":"Tint","year":"2014","journal-title":"Dev Neurosci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e19420","DOI":"10.1371\/journal.pone.0019420","article-title":"Coordinately regulated alternative splicing of genes involved in cholesterol biosynthesis and uptake","volume":"6","author":"Medina","year":"2011","journal-title":"PLoS ONE."},{"key":"B83","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/BF02254770","article-title":"Mevalonate regulates polysome distribution and blocks translation-dependent suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA: relationship to translational control","volume":"21","author":"Peffley","year":"1995","journal-title":"Somat Cell Mol Genet"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1194\/jlr.RA119000201","article-title":"Endogenous sterol intermediates of the mevalonate pathway regulate HMGCR degradation and SREBP-2 processing","volume":"60","author":"Chen","year":"2019","journal-title":"J Lipid Res"},{"key":"B85","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/S0022-2275(20)34935-X","article-title":"Post-translational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways","volume":"38","author":"Hinson","year":"1997","journal-title":"J Lipid Res"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1074\/jbc.271.5.2627","article-title":"Progesterone inhibits cholesterol biosynthesis in cultured cells. Accumulation of cholesterol precursors","volume":"271","author":"Metherall","year":"1996","journal-title":"J Biol Chem"},{"key":"B87","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1042\/bj20011777","article-title":"Inhibition of cholesterol biosynthesis by Delta22-unsaturated phytosterols via competitive inhibition of sterol Delta24-reductase in mammalian cells","volume":"366","author":"Fernandez","year":"2002","journal-title":"Biochem J."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.bbalip.2011.11.009","article-title":"The endogenous regulator 24(S),25-epoxycholesterol inhibits cholesterol synthesis at DHCR24 (Seladin-1)","volume":"1821","author":"Zerenturk","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B89","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","article-title":"Lipid metabolism reprogramming and its potential targets in cancer","volume":"38","author":"Cheng","year":"2018","journal-title":"Cancer Commun"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1158\/0008-5472.CAN-2148-2","article-title":"Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence","volume":"64","author":"Ettinger","year":"2004","journal-title":"Cancer Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"108181","DOI":"10.18632\/oncotarget.22569","article-title":"SREBP-2-driven transcriptional activation of human SND1 oncogene","volume":"8","author":"Armengol","year":"2017","journal-title":"Oncotarget"},{"key":"B92","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3389\/fonc.2018.00394","article-title":"Mevalonate metabolism in cancer stemness and trained immunity","volume":"8","author":"Gruenbacher","year":"2018","journal-title":"Front Oncol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.prostaglandins.2012.03.003","article-title":"Lipids and prostate cancer","volume":"98","author":"Suburu","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/cam4.695","article-title":"Blood lipids and prostate cancer: a Mendelian randomization analysis","volume":"5","author":"Bull","year":"2016","journal-title":"Cancer Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"288","DOI":"10.5534\/wjmh.180040","article-title":"Role of androgen receptor in prostate cancer: a review","volume":"37","author":"Fujita","year":"2019","journal-title":"World J Mens Health"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1210\/me.2005-0479","article-title":"Androgen activation of the sterol regulatory element-binding protein pathway: current insights","volume":"20","author":"Heemers","year":"2006","journal-title":"Mol Endocrinol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"30880","DOI":"10.1074\/jbc.M401615200","article-title":"Identification of an androgen response element in intron 8 of the sterol regulatory element-binding protein cleavage-activating protein gene allowing direct regulation by the androgen receptor","volume":"279","author":"Heemers","year":"2004","journal-title":"J Biol Chem"},{"key":"B98","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1210\/endo.137.10.8828509","article-title":"Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP","volume":"137","author":"Swinnen","year":"1996","journal-title":"Endocrinology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"12975","DOI":"10.1073\/pnas.94.24.12975","article-title":"Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins","volume":"94","author":"Swinnen","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B100","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41588-017-0027-2","article-title":"An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer","volume":"50","author":"Chen","year":"2018","journal-title":"Nat Genet"},{"key":"B101","doi-asserted-by":"publisher","first-page":"6533","DOI":"10.3892\/ol.2017.7025","article-title":"Stromal regulation of prostate cancer cell growth by mevalonate pathway enzymes HMGCS1 and HMGCR","volume":"14","author":"Ashida","year":"2017","journal-title":"Oncol Lett"},{"key":"B102","doi-asserted-by":"publisher","first-page":"14328","DOI":"10.1074\/jbc.RA118.004442","article-title":"Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC)","volume":"293","author":"Kong","year":"2018","journal-title":"J Biol Chem"},{"key":"B103","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00345-012-0844-y","article-title":"Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression?","volume":"31","author":"Todenhofer","year":"2013","journal-title":"World J Urol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"5265","DOI":"10.1038\/s41388-019-0791-9","article-title":"FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases\/AKT axis","volume":"38","author":"Seshacharyulu","year":"2019","journal-title":"Oncogene"},{"key":"B105","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/pcan.2012.14","article-title":"Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer","volume":"15","author":"Fukuma","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/s41388-018-0570-z","article-title":"CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-beta signaling","volume":"38","author":"Zhao","year":"2019","journal-title":"Oncogene"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/onc.2015.179","article-title":"Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP","volume":"35","author":"Ricoult","year":"2016","journal-title":"Oncogene"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e013053","DOI":"10.1136\/bmjopen-2016-013053","article-title":"Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: a systematic review and meta-analysis of randomised controlled trials","volume":"7","author":"Xu","year":"2017","journal-title":"BMJ Open"},{"key":"B109","doi-asserted-by":"publisher","first-page":"R121","DOI":"10.1186\/bcr3067","article-title":"Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers\u2013role of estrogen receptor and HER2 reactivation","volume":"13","author":"Wang","year":"2011","journal-title":"Breast Cancer Res"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1158\/1541-7786.MCR-19-0756","article-title":"Targeting the mevalonate pathway to overcome acquired anti-HER2 treatment resistance in breast cancer","volume":"17","author":"Sethunath","year":"2019","journal-title":"Mol Cancer Res"},{"key":"B111","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/ije\/dyx237","article-title":"Blood lipid genetic scores, the HMGCR gene and cancer risk: a Mendelian randomization study","volume":"47","author":"Orho-Melander","year":"2018","journal-title":"Int J Epidemiol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"15051","DOI":"10.1073\/pnas.0910258107","article-title":"Dysregulation of the mevalonate pathway promotes transformation","volume":"107","author":"Clendening","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B113","doi-asserted-by":"publisher","first-page":"35121","DOI":"10.1038\/srep35121","article-title":"HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes","volume":"6","author":"Di Benedetto","year":"2016","journal-title":"Sci Rep"},{"key":"B114","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12672-016-0262-5","article-title":"The contribution of cholesterol and its metabolites to the pathophysiology of breast cancer","volume":"7","author":"Baek","year":"2016","journal-title":"Horm Cancer"},{"key":"B115","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.tem.2014.10.001","article-title":"Cholesterol and breast cancer pathophysiology","volume":"25","author":"Nelson","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"B116","doi-asserted-by":"publisher","first-page":"4863757","DOI":"10.1155\/2018\/4863757","article-title":"Relationship of SNP rs2645429 in farnesyl-diphosphate farnesyltransferase 1 gene promoter with susceptibility to lung cancer","volume":"2018","author":"Dehghani","year":"2018","journal-title":"Int J Genomics"},{"key":"B117","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1164\/rccm.201404-0714OC","article-title":"Squalene synthase induces tumor necrosis factor receptor 1 enrichment in lipid rafts to promote lung cancer metastasis","volume":"190","author":"Yang","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.bbrc.2018.01.066","article-title":"FPPS mediates TGF-beta1-induced non-small cell lung cancer cell invasion and the EMT process via the RhoA\/Rock1 pathway","volume":"496","author":"Lin","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1111\/jcmm.13493","article-title":"Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma","volume":"22","author":"Wang","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/1759-7714.12944","article-title":"Squalene epoxidase promotes the proliferation and metastasis of lung squamous cell carcinoma cells though extracellular signal-regulated kinase signaling","volume":"10","author":"Ge","year":"2019","journal-title":"Thorac Cancer"},{"key":"B121","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/COC.0000000000000630","article-title":"Targeting the mevalonate pathway for treating lung cancer","volume":"43","author":"Fatehi Hassanabad","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41419-019-2054-7","article-title":"ASPP2 inhibits tumor growth by repressing the mevalonate pathway in hepatocellular carcinoma","volume":"10","author":"Liang","year":"2019","journal-title":"Cell Death Dis"},{"key":"B123","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bbalip.2018.11.004","article-title":"Channeling of newly synthesized fatty acids to cholesterol esterification limits triglyceride synthesis in SND1-overexpressing hepatoma cells","volume":"1864","author":"Navarro-Imaz","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B124","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/gutjnl-2018-317581","article-title":"Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans","volume":"69","author":"Che","year":"2019","journal-title":"Gut"},{"key":"B125","doi-asserted-by":"publisher","first-page":"21022","DOI":"10.18632\/oncotarget.24781","article-title":"Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma","volume":"9","author":"Ogura","year":"2018","journal-title":"Oncotarget"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s41467-019-09116-x","article-title":"A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma","volume":"10","author":"Syafruddin","year":"2019","journal-title":"Nat Commun"},{"key":"B127","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.2217\/fon-2019-0321","article-title":"LncRNA SNHG16 induces the SREBP2 to promote lipogenesis and enhance the progression of pancreatic cancer","volume":"15","author":"Yu","year":"2019","journal-title":"Future Oncol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.stem.2017.12.017","article-title":"Phospholipid remodeling and cholesterol availability regulate intestinal stemness and tumorigenesis","volume":"22","author":"Wang","year":"2018","journal-title":"Cell Stem Cell."},{"key":"B129","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.omto.2019.04.008","article-title":"Dual regulatory mechanisms of expression and mutation involving metabolism-related genes FDFT1 and UQCR5 during CLM","volume":"14","author":"Ma","year":"2019","journal-title":"Mol Ther Oncolytics"},{"key":"B130","doi-asserted-by":"publisher","first-page":"41404","DOI":"10.1038\/srep41404","article-title":"Cholesterol synthetase DHCR24 induced by insulin aggravates cancer invasion and progesterone resistance in endometrial carcinoma","volume":"7","author":"Dai","year":"2017","journal-title":"Sci Rep"},{"key":"B131","doi-asserted-by":"publisher","first-page":"e11830","DOI":"10.1097\/MD.0000000000011830","article-title":"DHCR24 predicts poor clinicopathological features of patients with bladder cancer: a STROBE-compliant study","volume":"97","author":"Liu","year":"2018","journal-title":"Medicine"},{"key":"B132","doi-asserted-by":"publisher","first-page":"e70987","DOI":"10.1371\/journal.pone.0070987","article-title":"MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells","volume":"8","author":"Li","year":"2013","journal-title":"PLoS ONE."},{"key":"B133","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1158\/1535-7163.MCT-13-0797","article-title":"Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling","volume":"13","author":"Li","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"B134","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1194\/jlr.M041335","article-title":"Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake","volume":"55","author":"Yang","year":"2014","journal-title":"J Lipid Res"},{"key":"B135","doi-asserted-by":"publisher","first-page":"13677","DOI":"10.1038\/srep13677","article-title":"MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer","volume":"5","author":"Yang","year":"2015","journal-title":"Sci Rep"},{"key":"B136","doi-asserted-by":"publisher","first-page":"17001","DOI":"10.1074\/jbc.C116.737346","article-title":"Fatostatin inhibits cancer cell proliferation by affecting mitotic microtubule spindle assembly and cell division","volume":"291","author":"Gholkar","year":"2016","journal-title":"J Biol Chem"},{"key":"B137","doi-asserted-by":"publisher","first-page":"7320","DOI":"10.1074\/jbc.M210283200","article-title":"Identification of bioactive molecules by adipogenesis profiling of organic compounds","volume":"278","author":"Choi","year":"2003","journal-title":"J Biol Chem"},{"key":"B138","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.chembiol.2009.07.007","article-title":"A small molecule that blocks fat synthesis by inhibiting the activation of SREBP","volume":"16","author":"Kamisuki","year":"2009","journal-title":"Chem Biol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41389-018-0076-0","article-title":"Fatostatin induces pro- and anti-apoptotic lipid accumulation in breast cancer","volume":"7","author":"Brovkovych","year":"2018","journal-title":"Oncogenesis"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.3892\/or.2018.6265","article-title":"Fatostatin suppresses growth and enhances apoptosis by blocking SREBP-regulated metabolic pathways in endometrial carcinoma","volume":"39","author":"Gao","year":"2018","journal-title":"Oncol Rep"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1194\/jlr.M069583","article-title":"Fatostatin blocks ER exit of SCAP but inhibits cell growth in a SCAP-independent manner","volume":"57","author":"Shao","year":"2016","journal-title":"J Lipid Res"},{"key":"B142","doi-asserted-by":"publisher","first-page":"41018","DOI":"10.18632\/oncotarget.5879","article-title":"Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"B143","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1042\/BJ20120545","article-title":"A key regulator of cholesterol homoeostasis, SREBP-2, can be targeted in prostate cancer cells with natural products","volume":"446","author":"Krycer","year":"2012","journal-title":"Biochem J."},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14717","article-title":"Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence","author":"Wei","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B145","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.3390\/ijms19103127","article-title":"Emodin sensitizes hepatocellular carcinoma cells to the anti-cancer effect of sorafenib through suppression of cholesterol metabolism","volume":"19","author":"Kim","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.3390\/ijms20194767","article-title":"Ursolic acid suppresses cholesterol biosynthesis and exerts anti-cancer effects in hepatocellular carcinoma cells","volume":"20","author":"Kim","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B147","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bcp.2014.06.018","article-title":"Induction of cholesterol biosynthesis by archazolid B in T24 bladder cancer cells","volume":"91","author":"Hamm","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"17321","DOI":"10.1073\/pnas.1008499107","article-title":"MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo","volume":"107","author":"Horie","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B149","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.bbrc.2018.08.205","article-title":"MicroRNA-98 regulates hepatic cholesterol metabolism via targeting sterol regulatory element-binding protein 2","volume":"504","author":"Geng","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B150","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1124\/jpet.110.174870","article-title":"Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression","volume":"336","author":"Kochuparambil","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"B151","doi-asserted-by":"publisher","first-page":"7231","DOI":"10.2147\/CMAR.S212643","article-title":"Statins induce cell apoptosis through a modulation of AKT\/FOXO1 pathway in prostate cancer cells","volume":"11","author":"Deng","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41416-018-0267-7","article-title":"Statins attenuate outgrowth of breast cancer metastases","volume":"119","author":"Beckwitt","year":"2018","journal-title":"Br J Cancer"},{"key":"B153","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/01913123.2018.1522406","article-title":"Atorvastatin induces autophagy in MDA-MB-231 breast cancer cells","volume":"42","author":"Hu","year":"2018","journal-title":"Ultrastruct Pathol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"3235021","DOI":"10.1155\/2019\/3235021","article-title":"Atorvastatin inhibits breast cancer cells by downregulating PTEN\/AKT pathway via promoting ras homolog family member B (RhoB)","volume":"2019","author":"Ma","year":"2019","journal-title":"Biomed Res Int"},{"key":"B155","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1002\/jcb.27544","article-title":"Lipophilic statins antagonistically alter the major epithelial-to-mesenchymal transition signaling pathways in breast cancer stem-like cells via inhibition of the mevalonate pathway","volume":"120","author":"Koohestanimobarhan","year":"2018","journal-title":"J Cell Biochem"},{"key":"B156","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.18632\/oncotarget.6304","article-title":"Simvastatin-induced breast cancer cell death and deactivation of PI3K\/Akt and MAPK\/ERK signalling are reversed by metabolic products of the mevalonate pathway","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"B157","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10549-015-3645-3","article-title":"Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a","volume":"154","author":"Wolfe","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"B158","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1111\/cas.13748","article-title":"Simvastatin functions as a heat shock protein 90 inhibitor against triple-negative breast cancer","volume":"109","author":"Kou","year":"2018","journal-title":"Cancer Sci"},{"key":"B159","doi-asserted-by":"publisher","first-page":"13710","DOI":"10.1096\/fj.201901388R","article-title":"Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway","volume":"33","author":"Wang","year":"2019","journal-title":"FASEB J."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3892\/or.2016.4897","article-title":"Atorvastatin partially inhibits the epithelial-mesenchymal transition in A549 cells induced by TGF-beta1 by attenuating the upregulation of SphK1","volume":"36","author":"Fan","year":"2016","journal-title":"Oncol Rep"},{"key":"B161","doi-asserted-by":"publisher","first-page":"10345","DOI":"10.18632\/oncotarget.7213","article-title":"Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2\/PPARgamma-dependent pathway","volume":"7","author":"Walther","year":"2016","journal-title":"Oncotarget"},{"key":"B162","doi-asserted-by":"publisher","first-page":"4819","DOI":"10.1007\/s13277-015-3134-7","article-title":"Simvastatin downregulates expression of TGF-betaRII and inhibits proliferation of A549 cells via ERK","volume":"36","author":"Shang","year":"2015","journal-title":"Tumour Biol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"e72033","DOI":"10.1371\/journal.pone.0072033","article-title":"Stimulation of osteoclast formation by RANKL requires interferon regulatory factor-4 and is inhibited by simvastatin in a mouse model of bone loss","volume":"8","author":"Nakashima","year":"2013","journal-title":"PLoS ONE."},{"key":"B164","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ebiom.2017.04.028","article-title":"Statins as inhibitors of lung cancer bone metastasis","volume":"19","author":"Sarkar","year":"2017","journal-title":"EBioMedicine"},{"key":"B165","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ebiom.2017.04.017","article-title":"Fluvastatin prevents lung adenocarcinoma bone metastasis by triggering autophagy","volume":"19","author":"Yang","year":"2017","journal-title":"EBioMedicine"},{"key":"B166","doi-asserted-by":"publisher","first-page":"e2626","DOI":"10.1038\/cddis.2016.472","article-title":"Simvastatin-induced cell cycle arrest through inhibition of STAT3\/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis"},{"key":"B167","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12032-016-0845-6","article-title":"Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma","volume":"33","author":"Higashi","year":"2016","journal-title":"Med Oncol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.3892\/mmr.2014.2976","article-title":"Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression","volume":"11","author":"Huang","year":"2015","journal-title":"Mol Med Rep"},{"key":"B169","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3892\/ijo.2010.892","article-title":"Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression and ROCK","volume":"38","author":"Relja","year":"2011","journal-title":"Int J Oncol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1158\/1078-0432.CCR-07-5232","article-title":"Statin-dependent suppression of the Akt\/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma","volume":"14","author":"Woodard","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B171","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1038\/cddis.2013.44","article-title":"HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway","volume":"4","author":"Qi","year":"2013","journal-title":"Cell Death Dis"},{"key":"B172","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1158\/1940-6207.CAPR-09-0059","article-title":"Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence","volume":"3","author":"Zheng","year":"2010","journal-title":"Cancer Prev Res"},{"key":"B173","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2407-10-103","article-title":"Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance","volume":"10","author":"Martirosyan","year":"2010","journal-title":"BMC Cancer"},{"key":"B174","doi-asserted-by":"publisher","first-page":"eaaq1240","DOI":"10.1126\/scitranslmed.aaq1240","article-title":"Statins enhance efficacy of venetoclax in blood cancers","volume":"10","author":"Lee","year":"2018","journal-title":"Sci Transl Med."},{"key":"B175","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ygyno.2019.05.022","article-title":"Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth","volume":"154","author":"Kim","year":"2019","journal-title":"Gynecol Oncol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1158\/0008-5472.CAN-19-0644","article-title":"Targeting the metabolic response to statin-mediated oxidative stress produces a synergistic antitumor response","volume":"80","author":"McGregor","year":"2020","journal-title":"Cancer Res"},{"key":"B177","first-page":"913","article-title":"Inhibition of survivin is associated with zoledronic acid-induced apoptosis of prostate cancer cells","volume":"36","author":"Fragni","year":"2016","journal-title":"Anticancer Res"},{"key":"B178","doi-asserted-by":"publisher","first-page":"807","DOI":"10.2174\/1568009619666190115142858","article-title":"Zoledronic Acid inhibits the RhoA-mediated amoeboid motility of prostate cancer cells","volume":"19","author":"Pietrovito","year":"2019","journal-title":"Curr Cancer Drug Targets"},{"key":"B179","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/10520295.2017.1387286","article-title":"Zoledronic acid overcomes chemoresistance by sensitizing cancer stem cells to apoptosis","volume":"93","author":"Rouhrazi","year":"2018","journal-title":"Biotech Histochem"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.juro.2010.11.045","article-title":"Zoledronic acid induces autophagic cell death in human prostate cancer cells","volume":"185","author":"Lin","year":"2011","journal-title":"J Urol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1464-4096.2004.04831.x","article-title":"Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation","volume":"94","author":"Coxon","year":"2004","journal-title":"BJU Int"},{"key":"B182","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12885-019-5379-9","article-title":"Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Cancer"},{"key":"B183","doi-asserted-by":"publisher","first-page":"20753","DOI":"10.18632\/oncotarget.8012","article-title":"Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors","volume":"7","author":"Kopecka","year":"2016","journal-title":"Oncotarget"},{"key":"B184","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/CAD.0b013e3283400a05","article-title":"Zoledronic acid induces cell-cycle prolongation in murine lung cancer cells by perturbing cyclin and Ras expression","volume":"22","author":"Li","year":"2011","journal-title":"Anticancer Drugs"},{"key":"B185","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.bbrc.2015.10.089","article-title":"The bisphosphonate zoledronic acid effectively targets lung cancer cells by inhibition of protein prenylation","volume":"467","author":"Xie","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B186","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jgh.12715","article-title":"Effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathway","volume":"30","author":"Honda","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"B187","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2012.12.021","article-title":"Potent antitumor activity of zoledronic acid-induced Vgamma9Vdelta2 T cells against primary effusion lymphoma","volume":"331","author":"Goto","year":"2013","journal-title":"Cancer Lett"},{"key":"B188","doi-asserted-by":"publisher","first-page":"118","DOI":"10.18632\/oncotarget.9497","article-title":"Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts","volume":"8","author":"Comito","year":"2017","journal-title":"Oncotarget"},{"key":"B189","doi-asserted-by":"publisher","first-page":"8818","DOI":"10.1158\/0008-5472.CAN-05-0540","article-title":"The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer","volume":"65","author":"Miwa","year":"2005","journal-title":"Cancer Res"},{"key":"B190","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2407-7-8","article-title":"Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines","volume":"7","author":"Koshimune","year":"2007","journal-title":"BMC Cancer"},{"key":"B191","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/sj.bjc.6603423","article-title":"A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo","volume":"95","author":"Sato","year":"2006","journal-title":"Br J Cancer"},{"key":"B192","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1007\/s13277-015-3140-9","article-title":"Effects of zoledronic acid and docetaxel on small GTP-binding proteins in prostate cancer","volume":"36","author":"Jones","year":"2015","journal-title":"Tumour Biol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jbo.2014.02.001","article-title":"Zoledronic acid and atorvastatin inhibit alphavbeta3-mediated adhesion of breast cancer cells","volume":"3","author":"Wilke","year":"2014","journal-title":"J Bone Oncol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1054\/bjoc.2001.1727","article-title":"The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel","volume":"84","author":"Jagdev","year":"2001","journal-title":"Br J Cancer"},{"key":"B195","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canlet.2016.03.004","article-title":"Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells","volume":"375","author":"Gobel","year":"2016","journal-title":"Cancer Lett"},{"key":"B196","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.3892\/or.2016.4741","article-title":"Zoledronic acid increases the antitumor effect of gefitinib treatment for non-small cell lung cancer with EGFR mutations","volume":"35","author":"Feng","year":"2016","journal-title":"Oncol Rep"},{"key":"B197","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1158\/0008-5472.CAN-15-2613","article-title":"The role of cholesterol in cancer","volume":"76","author":"Kuzu","year":"2016","journal-title":"Cancer Res"},{"key":"B198","first-page":"219","article-title":"The role of cholesterol metabolism in cancer","volume":"9","author":"Ding","year":"2019","journal-title":"Am J Cancer Res"},{"key":"B199","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.dld.2013.02.002","article-title":"Statins: perspectives in cancer therapeutics","volume":"45","author":"Corcos","year":"2013","journal-title":"Dig Liver Dis"},{"key":"B200","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2174\/1574892812666171129141211","article-title":"Targeting mevalonate pathway in cancer treatment: repurposing of statins","volume":"13","author":"Iannelli","year":"2018","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"B201","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1038\/ajg.2009.574","article-title":"Long-term use of statins and risk of colorectal cancer: a population-based study","volume":"104","author":"Singh","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/ajg.2010.475","article-title":"Statin use and the risk of liver cancer: a population-based case-control study","volume":"106","author":"Chiu","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1378\/chest.06-0931","article-title":"Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans","volume":"131","author":"Khurana","year":"2007","journal-title":"Chest"},{"key":"B204","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1097\/COC.0000000000000579","article-title":"Statins as potential therapeutics for lung cancer: molecular mechanisms and clinical outcomes","volume":"42","author":"Fatehi Hassanabad","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41419-019-1322-x","article-title":"Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells","volume":"10","author":"Gobel","year":"2019","journal-title":"Cell Death Dis"},{"key":"B206","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.euf.2016.05.004","article-title":"statin use and prostate cancer survival in the finnish randomized study of screening for prostate cancer","volume":"3","author":"Murtola","year":"2017","journal-title":"Eur Urol Focus"},{"key":"B207","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-017-4246-0","article-title":"The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis","volume":"164","author":"Liu","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"B208","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2147\/DDDT.S187690","article-title":"Statin use and prognosis of lung cancer: a systematic review and meta-analysis of observational studies and randomized controlled trials","volume":"13","author":"Xia","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"B209","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3349\/ymj.2019.60.12.1203","article-title":"Effect of statin use on liver cancer mortality considering hypercholesterolemia and obesity in patients with non-cirrhotic chronic hepatitis B","volume":"60","author":"Kim","year":"2019","journal-title":"Yonsei Med J."},{"key":"B210","doi-asserted-by":"publisher","first-page":"e0189233","DOI":"10.1371\/journal.pone.0189233","article-title":"Statin use is associated with improved survival in ovarian cancer: a retrospective population-based study","volume":"12","author":"Couttenier","year":"2017","journal-title":"PLoS ONE."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41395-018-0169-6","article-title":"The association between statin use after diagnosis and mortality risk in patients with esophageal cancer: a retrospective cohort study of United States veterans","volume":"113","author":"Nguyen","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"B212","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/ijc.30526","article-title":"Effects of statins on cancer mortality and progression: a systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals","volume":"140","author":"Mei","year":"2017","journal-title":"Int J Cancer"},{"key":"B213","doi-asserted-by":"publisher","first-page":"e0209486","DOI":"10.1371\/journal.pone.0209486","article-title":"Statin therapy in the treatment of active cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Farooqi","year":"2018","journal-title":"PLoS ONE."},{"key":"B214","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.2217\/fon-2017-0543","article-title":"Statins use and cancer: an update","volume":"14","author":"Zaleska","year":"2018","journal-title":"Future Oncol"},{"key":"B215","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.lungcan.2016.07.006","article-title":"The effect of statins on survival in patients with stage IV lung cancer","volume":"99","author":"Lin","year":"2016","journal-title":"Lung Cancer"},{"key":"B216","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00277-011-1276-2","article-title":"Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma","volume":"90","author":"Hus","year":"2011","journal-title":"Ann Hematol"},{"key":"B217","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.leukres.2018.01.021","article-title":"Report of the relapsed\/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)","volume":"67","author":"Advani","year":"2018","journal-title":"Leuk Res"},{"key":"B218","doi-asserted-by":"publisher","first-page":"e0171137","DOI":"10.1371\/journal.pone.0171137","article-title":"Statin improves survival in patients with EGFR-TKI lung cancer: a nationwide population-based study","volume":"12","author":"Hung","year":"2017","journal-title":"PLoS ONE."},{"key":"B219","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/bjc.2013.762","article-title":"Statin use is not associated with reduced risk of skin cancer: a meta-analysis","volume":"110","author":"Li","year":"2014","journal-title":"Br J Cancer"},{"key":"B220","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/bjc.2017.139","article-title":"Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study","volume":"116","author":"Gray","year":"2017","journal-title":"Br J Cancer"},{"key":"B221","doi-asserted-by":"publisher","first-page":"e29849","DOI":"10.1371\/journal.pone.0029849","article-title":"Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy","volume":"7","author":"Emberson","year":"2012","journal-title":"PLoS ONE."},{"key":"B222","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ctrv.2018.06.010","article-title":"The poor design of clinical trials of statins in oncology may explain their failure - lessons for drug repurposing","volume":"69","author":"Abdullah","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"B223","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/14656566.2019.1574754","article-title":"Zoledronic acid for the treatment of prostate cancer","volume":"20","author":"Finianos","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"B224","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CAD.0000000000000020","article-title":"Zoledronic acid in the treatment of metastatic breast cancer","volume":"25","author":"Lluch","year":"2014","journal-title":"Anticancer Drugs"},{"key":"B225","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s12149-018-1278-4","article-title":"Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial","volume":"32","author":"Seider","year":"2018","journal-title":"Ann Nucl Med"},{"key":"B226","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S1470-2045(15)00489-1","article-title":"Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data","volume":"17","author":"Vale","year":"2016","journal-title":"Lancet Oncol"},{"key":"B227","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1006\/bbrc.1999.1499","article-title":"Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates","volume":"264","author":"van Beek","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"B228","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/CIA.S7282","article-title":"Role of zoledronic acid in the prevention and treatment of osteoporosis","volume":"6","author":"Rakel","year":"2011","journal-title":"Clin Interv Aging"},{"key":"B229","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pharmthera.2015.11.008","article-title":"Bisphosphonates for cancer treatment: mechanisms of action and lessons from clinical trials","volume":"158","author":"Van Acker","year":"2016","journal-title":"Pharmacol Ther"},{"key":"B230","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/cncr.11128","article-title":"Antitumor effects of bisphosphonates","volume":"97","author":"Green","year":"2003","journal-title":"Cancer"},{"key":"B231","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jbo.2013.12.001","article-title":"The anti-tumour effects of zoledronic acid","volume":"3","author":"Zekri","year":"2014","journal-title":"J Bone Oncol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijrobp.2016.06.2453","article-title":"Zoledronic acid in first-line treatment of prostate cancer","volume":"97","author":"Pinkawa","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B233","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1586\/era.11.13","article-title":"Zoledronic acid for adjuvant use in patients with breast cancer","volume":"11","author":"Ressler","year":"2011","journal-title":"Expert Rev Anticancer Ther"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01510\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:29:32Z","timestamp":1616977772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01510\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,21]]},"references-count":233,"alternative-id":["10.3389\/fonc.2020.01510"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.01510","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,21]]},"article-number":"1510"}}